during the swiftly evolving subject of cancer therapeutics, comprehending the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is very important for building efficient solutions. Probably the most promising methods is using in vitro bystander impact assays, which Participate in a pivotal position in maximizing therapeutic efficacy. These ass